Literature DB >> 3556378

Lidocaine protein binding in preeclampsia.

M B Bottorff, J A Pieper, B A Boucher, T J Hoon, J Ramanathan, B M Sibai.   

Abstract

The effect of preeclampsia on the binding of lidocaine to serum proteins was studied in 25 term parturients with severe preeclampsia and in 21 normal parturients serving as controls. There were no statistically significant differences in mean lidocaine free fraction, binding ratio, or serum AAG levels in the control vs preeclamptic patients, respectively. Binding ratio was strongly correlated with AAG concentration for the control (r = 0.91) and preeclamptic (r = 0.85) patients. A statistically significant difference was observed in the slopes of the lines relating binding ratio to AAG. Preeclampsia had little affect on serum AAG concentrations and lidocaine binding ratio. Preeclampsia may alter the interaction of lidocaine with binding sites on AAG without a significant change in lidocaine free fraction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556378     DOI: 10.1007/BF00541302

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis.

Authors:  J D Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

2.  Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection.

Authors:  L S Reisner; B N Hochman; M H Plumer
Journal:  Anesth Analg       Date:  1980-06       Impact factor: 5.108

3.  Cardiac arrest following regional anesthesia with etidocaine or bupivacaine.

Authors:  G A Albright
Journal:  Anesthesiology       Date:  1979-10       Impact factor: 7.892

4.  Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein.

Authors:  O G Nilsen; P Leren; I Aakesson; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1978-03-15       Impact factor: 5.858

5.  Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

Authors:  M Wood; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

6.  Epidural bupivacaine, chloroprocaine, or lidocaine for cesarean section--maternal and neonatal effects.

Authors:  T K Abboud; K C Kim; R Noueihed; B R Kuhnert; N DerMardirossian; J Moumdjian; F Sarkis; S Nagappala
Journal:  Anesth Analg       Date:  1983-10       Impact factor: 5.108

7.  Factors influencing serum protein binding of lidocaine in humans.

Authors:  P J McNamara; R L Slaughter; J A Pieper; M G Wyman; D Lalka
Journal:  Anesth Analg       Date:  1981-06       Impact factor: 5.108

8.  The pharmacokinetics and maternal and neonatal effects of epidural lidocaine in preeclampsia.

Authors:  J Ramanathan; M Bottorff; J N Jeter; M Khalil; B M Sibai
Journal:  Anesth Analg       Date:  1986-02       Impact factor: 5.108

9.  Alpha1-acid glycoprotein concentration and protein binding in trauma.

Authors:  D J Edwards; D Lalka; F Cerra; R L Slaughter
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

10.  Maternal, fetal, and neonatal effects of lidocaine with and without epinephrine for epidural anesthesia in obstetrics.

Authors:  T K Abboud; S David; S Nagappala; J Costandi; T Yanagi; S Haroutunian; S U Yeh
Journal:  Anesth Analg       Date:  1984-11       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.